Advanced chronic kidney disease

Disease

1 paper

Funding

1 grant since 2020

Instituto de Salud Carlos III

Latest

Nov 2025: 2Dec 2025: 2Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 6Sep 2026: 5Oct 2026: 219 in 12 months
Clinical Kidney Journal

Lower blood pressure linked to lower risk in advanced kidney disease

The hazard ratio, comparing heart and blood vessel risk over time, was 0.93 for pressures of 120 to below 130 versus 130 to below 140 millimetres of mercury.The hazard ratio, comparing heart and blood vessel risk over time, was 0.93 for pressures of 120 to below 130 versus 130 to below 140 millimetres of mercury.

Cohort study of 23,317 adults with chronic kidney disease, against patients with SBP 130-<140 mmHgKidney

Limit: Excluding early deaths selected survivors; SBP <120 mmHg predicted higher mortality in the broader cohort

Frontiers in Neurology

Starting lithium linked to lower death and dementia risks

Estimated five-year risks were 6.61% versus 10.65% for death and 3.51% versus 4.85% for dementia, comparing lithium with valproate.Estimated five-year risks were 6.61% versus 10.65% for death and 3.51% versus 4.85% for dementia, comparing lithium with valproate.

Cohort study of 22,098 peopleLithium
Clinical Journal of the American Society of Nephrology

SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes

In older veterans, primary kidney and survival risks matched with a hazard ratio of 1.00, though SGLT2 inhibitors showed lower sustained kidney decline and end-stage…In older veterans, primary kidney and survival risks matched with a hazard ratio of 1.00, though SGLT2 inhibitors showed lower sustained kidney decline and end-stage disease.

Cohort study of 78,354 peopleKidney